MC1R and melanoma: Positron emission tomography (PET) imaging of an MC1R-targeted peptide 68Ga-DOTA-GGNle-CycNSHhex in melanoma patients has established clinical proof-of-concept of MC1R as a target for imaging and therapy [4].